CUREGENIX, INC.

Organization

GUANGZHOU, GD, CN

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Liposome formulation for delivery of Wnt signal pathway inhibitor
- Patent number 10,702,473
- Issue date Jul 7, 2020
- Curegenix, Inc.
- Yuhong Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for treatment of cancer
- Patent number 10,660,889
- Issue date May 26, 2020
- Curegenix, Inc.
- Songzhu An
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for treatment of fibrosis diseases
- Patent number 10,285,988
- Issue date May 14, 2019
- CUREGENIX, INC.
- Songzhu An
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for treatment of cancer
- Patent number 10,238,652
- Issue date Mar 26, 2019
- CUREGENIX, INC.
- Songzhu An
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compound as WNT signaling inhibitor, composition, and use thereof
- Patent number 10,087,181
- Issue date Oct 2, 2018
- CUREGENIX, INC.
- Songzhu An
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for treatment of fibrosis diseases
- Patent number 9,744,169
- Issue date Aug 29, 2017
- Curegenix, Inc.
- Songzhu An
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for treatment of cancer
- Patent number 9,713,612
- Issue date Jul 25, 2017
- Curegenix, Inc.
- Songzhu An
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compound as WNT signaling inhibitor, composition, and use thereof
- Patent number 9,556,144
- Issue date Jan 31, 2017
- Curegenix, Inc.
- Songzhu An
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound as antagonist of lysophosphatidic acid receptor, compositi...
- Patent number 8,785,442
- Issue date Jul 22, 2014
- Curegenix, Inc.
- Songzhu An
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS FOR TREATMENT OF FIBROSIS DISEASES
- Publication number 20190209558
- Publication date Jul 11, 2019
- CUREGENIX, INC.
- Songzhu AN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TREATMENT OF CANCER
- Publication number 20190142827
- Publication date May 16, 2019
- Curegenix, Inc.
- Songzhu AN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LIPOSOME FORMULATION FOR DELIVERY OF WNT SIGNAL PATHWAY INHIBITOR A...
- Publication number 20190022002
- Publication date Jan 24, 2019
- Curegenix, Inc.
- Yuhong Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LIPOSOME FORMULATION FOR DELIVERY OF WNT SIGNAL PATHWAY INHIBITOR
- Publication number 20190022003
- Publication date Jan 24, 2019
- Curegenix, Inc.
- Yuhong Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for Treatment of Fibrosis Diseases
- Publication number 20170312277
- Publication date Nov 2, 2017
- CUREGENIX, INC.
- Songzhu AN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for Treatment of Cancer
- Publication number 20170304302
- Publication date Oct 26, 2017
- CUREGENIX, INC.
- Songzhu AN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compound as WNT Signaling Inhibitor, Composition, and Use Thereof
- Publication number 20170073344
- Publication date Mar 16, 2017
- CUREGENIX, INC.
- Songzhu An
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for Treatment of Fibrosis Diseases
- Publication number 20160000779
- Publication date Jan 7, 2016
- CUREGENIX, INC.
- Songzhu AN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for Treatment of Cancer
- Publication number 20160000780
- Publication date Jan 7, 2016
- CUREGENIX, INC.
- Songzhu AN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compound as WNT Signaling Inhibitor, Composition, and Use Thereof
- Publication number 20150119387
- Publication date Apr 30, 2015
- Curegenix Inc.
- Songzhou An
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND AS ANTAGONIST OF LYSOPHOSPHATIDIC ACID RECEPTOR, COMPOSITI...
- Publication number 20140031353
- Publication date Jan 30, 2014
- CUREGENIX, INC.
- Songzhu An
- C07 - ORGANIC CHEMISTRY

CUREGENIX, INC.

Organization

Patents Grantslast 30 patents

Liposome formulation for delivery of Wnt signal pathway inhibitor

Compounds for treatment of cancer

Compounds for treatment of fibrosis diseases

Compounds for treatment of cancer

Compound as WNT signaling inhibitor, composition, and use thereof

Compounds for treatment of fibrosis diseases

Compounds for treatment of cancer

Compound as WNT signaling inhibitor, composition, and use thereof

Compound as antagonist of lysophosphatidic acid receptor, compositi...

Patents Applicationslast 30 patents

COMPOUNDS FOR TREATMENT OF FIBROSIS DISEASES

COMPOUNDS FOR TREATMENT OF CANCER

LIPOSOME FORMULATION FOR DELIVERY OF WNT SIGNAL PATHWAY INHIBITOR A...

LIPOSOME FORMULATION FOR DELIVERY OF WNT SIGNAL PATHWAY INHIBITOR

Compounds for Treatment of Fibrosis Diseases

Compounds for Treatment of Cancer

Compound as WNT Signaling Inhibitor, Composition, and Use Thereof

Compounds for Treatment of Fibrosis Diseases

Compounds for Treatment of Cancer

Compound as WNT Signaling Inhibitor, Composition, and Use Thereof

COMPOUND AS ANTAGONIST OF LYSOPHOSPHATIDIC ACID RECEPTOR, COMPOSITI...